These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7615177)

  • 21. Association between muscle trauma and heterotopic ossification in spinal cord injured patients: reflections on their causal relationship and the diagnostic value of ultrasonography.
    Snoecx M; De Muynck M; Van Laere M
    Paraplegia; 1995 Aug; 33(8):464-8. PubMed ID: 7478741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of the three-phase bone scan in the early diagnosis of heterotopic ossification (HO) and in the evaluation of Didronel therapy.
    Freed JH; Hahn H; Menter R; Dillon T
    Paraplegia; 1982 Aug; 20(4):208-16. PubMed ID: 6215609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between alendronate, serum alkaline phosphatase level, and heterotopic ossification in individuals with spinal cord injury.
    Ploumis A; Donovan JM; Olurinde MO; Clark DM; Wu JC; Sohn DJ; O'Connor KC
    J Spinal Cord Med; 2015 Mar; 38(2):193-8. PubMed ID: 24820653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous disodium etidronate therapy in spinal cord injury patients with heterotopic ossification.
    Banovac K; Gonzalez F; Wade N; Bowker JJ
    Paraplegia; 1993 Oct; 31(10):660-6. PubMed ID: 8259329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of heterotopic ossification after spinal cord injury.
    Banovac K; Gonzalez F; Renfree KJ
    J Spinal Cord Med; 1997 Jan; 20(1):60-5. PubMed ID: 9097258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandin E2 measurements: their value in the early diagnosis of heterotopic ossification in spinal cord injury patients.
    Schurch B; Capaul M; Vallotton MB; Rossier AB
    Arch Phys Med Rehabil; 1997 Jul; 78(7):687-91. PubMed ID: 9228869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical observations on fractures and heterotopic ossification in the spinal cord and traumatic brain injured populations.
    Garland DE
    Clin Orthop Relat Res; 1988 Aug; (233):86-101. PubMed ID: 3135969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and risk factors in the appearance of heterotopic ossification in spinal cord injury.
    Bravo-Payno P; Esclarin A; Arzoz T; Arroyo O; Labarta C
    Paraplegia; 1992 Oct; 30(10):740-5. PubMed ID: 1448303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterotopic ossification in the hand of a patient with spinal cord injury.
    Lynch C; Pont A; Weingarden SI
    Arch Phys Med Rehabil; 1981 Jun; 62(6):291-3. PubMed ID: 6786254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radionuclide assessment of heterotopic ossification in spinal cord injury patients.
    Prakash V
    J Am Paraplegia Soc; 1983 Jan; 6(1):10-2. PubMed ID: 6310049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of serum creatine kinase in early diagnosis of heterotopic ossification.
    Sherman AL; Williams J; Patrick L; Banovac K
    J Spinal Cord Med; 2003; 26(3):227-30. PubMed ID: 14997963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pelvic MRI in spinal cord injury patients: incidence of muscle signal change and early heterotopic ossification.
    McKean D; Ather S; Gandhi A; Hubble T; Belci M; Tiberti S; Papanikitas J; Yanny S; King D; Hughes R; Meagher T; de Heredria LL
    Spinal Cord; 2021 Jun; 59(6):635-641. PubMed ID: 32873893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterotopic ossification.
    Shehab D; Elgazzar AH; Collier BD
    J Nucl Med; 2002 Mar; 43(3):346-53. PubMed ID: 11884494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pelvic heterotopic ossification: MR imaging characteristics.
    Ledermann HP; Schweitzer ME; Morrison WB
    Radiology; 2002 Jan; 222(1):189-95. PubMed ID: 11756725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for heterotopic ossification in patients with spinal cord injury: a case-control study of 264 patients.
    Citak M; Suero EM; Backhaus M; Aach M; Godry H; Meindl R; Schildhauer TA
    Spine (Phila Pa 1976); 2012 Nov; 37(23):1953-7. PubMed ID: 22614800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diphosphonate treatment for heterotopic ossification in spinal cord injury patients.
    Garland DE; Alday B; Venos KG; Vogt JC
    Clin Orthop Relat Res; 1983 Jun; (176):197-200. PubMed ID: 6406123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurogenic heterotopic ossification of the hands in a patient with spinal cord injury: a case report.
    Bendeddouche I; Aissaoui N; Hajjaj-Hassouni N
    Spinal Cord; 2011 Oct; 49(10):1079-81. PubMed ID: 21301470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for heterotopic ossification in spinal cord injury.
    Lal S; Hamilton BB; Heinemann A; Betts HB
    Arch Phys Med Rehabil; 1989 May; 70(5):387-90. PubMed ID: 2497715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resection of heterotopic ossification in patients with spinal cord injuries.
    Garland DE; Orwin JF
    Clin Orthop Relat Res; 1989 May; (242):169-76. PubMed ID: 2495875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical analysis of heterotopic ossification in spinal cord injury patients.
    Chantraine A; Nusgens B; Lapiere CM
    Paraplegia; 1995 Jul; 33(7):398-401. PubMed ID: 7478729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.